4 recruiting, 3 not yet recruiting, 2 unknown. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Recruiting 4, Not yet recruiting 3, Unknown 2 |
Follow Aortic Arch Syndromes: new trials by email Literature Review of Aortic Arch Syndromes trials Research Report on Aortic Arch Syndromes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis Vanakizumab, Ivarmacitinib, Prednisone - Takayasu Arteritis (TAK) | Phase 4 | Not yet recruiting | Chinese SLE Treatment And Research Group | 180 | 2026-04-01 | 2026-03-05 |
| Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases Dengue 1,2,3,4 (attenuated) vaccine - Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis (JIA) | Phase 4 | Recruiting | University of Sao Paulo General Hospital | 477 | 2026-03-16 | 2026-07-20 |
| Effect of Pirfenidone on TA Fibrosis Pirfenidone Capsules, Placebo - Takayasu Arteritis | Phase 4 | Not yet recruiting | Shanghai Zhongshan Hospital | 92 | 2025-12-20 | 2026-01-08 |
| The Efficacy and Safety of Deucravacitinib in Takayasu's Arteritis Deucravacitinib, Adalimumab - Takayasu Arteritis (TAK) | Phase 4 | Not yet recruiting | Chinese SLE Treatment And Research Group | 50 | 2025-06-15 | 2025-06-10 |
| A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis Prednisone, Methotrexate, Tocilizumab - Takayasu Arteritis | Phase 4 | Recruiting | Shanghai Zhongshan Hospital | 124 | 2024-06-28 | 2024-10-17 |
| Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis Adalimumab Injection, Tofacitinib 5 MG - Takayasu Arteritis | Phase 4 | Unknown | Chinese SLE Treatment And Research Group | 100 | 2022-01-05 | 2023-07-24 |
| Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis Tofacitinib, Methotrexate - Takayasu Arteritis | Phase 4 | Recruiting | Shanghai Zhongshan Hospital | 76 | 2021-11-01 | 2024-10-15 |
| A Pilot Study in Severe Patients With Takayasu Arteritis. Tocilizumab, Adalimumab - Takayasu Arteritis, Tocilizumab | Phase 4 | Recruiting | Shanghai Zhongshan Hospital | 40 | 2020-03-01 | 2021-08-10 |
| Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients Methotrexate Tablets, Tofacitinib tablet - Takayasu Arteritis, Methotrexate | Phase 4 | Unknown | Shanghai Zhongshan Hospital | 130 | 2020-03-01 | 2020-06-12 |
Takayasu Arteritis (9) · Antiphospholipid Syndrome (1) · Arthritis, Juvenile (1) · Arthritis, Psoriatic (1) · Arthritis, Rheumatoid (1) · Axial Spondyloarthritis (1) · Fibrosis (1) · Granulomatosis with Polyangiitis (1) · Inflammation (1) · Inhibition, Psychological (1) · Lupus Erythematosus, Systemic (1) · Microscopic Polyangiitis (1) · Myositis (1) · Recurrence (1) · Scleroderma, Systemic (1)
Aortic Diseases (9) · Arteritis (9) · Cardiovascular Diseases (9) · Skin Diseases (9) · Skin Diseases, Vascular (9) · Skin and Connective Tissue Diseases (9) · Vascular Diseases (9) · Vasculitis (9) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Ankylosis (1) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Arthritis (1) · Autoimmune Diseases (1)
Adalimumab (4) · tofacitinib (4) · Methotrexate (3) · Prednisone (2) · tocilizumab (2) · Glucocorticoids (1) · Vaccines (1) · deucravacitinib (1) · ivarmacitinib (1) · pirfenidone (1)
Shanghai Zhongshan Hospital (5) · Chinese SLE Treatment And Research Group (3) · University of Sao Paulo General Hospital (1)
China (7) · Brazil (1)
Lindi Jiang, PhD (3) · Lindi Jiang, Ph.D., M.D. (1) · Xiaofeng Zeng, MD (1) · Xinping Tian, MD (1)